Market Tracker

01/30 11:02pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.04
Data as of Jan 30
 -0.10 / -1.95%
Today’s Change
4.31
Today|||52-Week Range
28.60
+10.53%
Year-to-Date

Today’s Trading

Previous close5.14
Today’s open5.21
Day’s range4.95 - 5.25
Volume29,349
Average volume (3 months)55,966
Market cap$54.6M
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...-0.09-3.96%
COCPCocrystal Pharma Inc-0.00-0.44%
PARNParnell Pharmaceutic...+0.20+4.76%
CTRVContraVir Pharmaceut...-0.13-4.73%
Data as of 3:58pm ET, 01/30/2015

Financials

Last reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts